Founder and CEO

Hexagon announces organisational updates and further details around the potential spin-off of Octave

Hexagon makes organizational changes ahead of spin-off - two executives move to Octave

Octave Bioscience to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Ripping up the rulebook: Marketing’s new frontier

Denials Specialist

Octave Bioscience is at the forefront of precision care, delivering data-driven insights for neurodegenerative diseases. The Denials Specialist serves as the primary point of contact for the identification, categorization, and resolution of denied claims, involving the review of claims and effective appeal processes.

Sign up with Google

Sign in with Google